Compounds > tetrakis-mu-acetylsalicylato-dicopper(ii)
Page last updated: 2024-08-26

tetrakis-mu-acetylsalicylato-dicopper(ii) and salicylates

tetrakis-mu-acetylsalicylato-dicopper(ii) has been researched along with salicylates in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giroud, JP; Huy, DP; Maman, L; Roch-Arveiller, M; Sorenson, JR1
Iqbal, MS; Pervez, H; Saeed, M; Sher, M1

Trials

1 trial(s) available for tetrakis-mu-acetylsalicylato-dicopper(ii) and salicylates

ArticleYear
Pharmacokinetic study of copper (II) acetylsalicylate.
    Biological trace element research, 2008, Volume: 124, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aspirin; Chromatography, High Pressure Liquid; Female; Humans; Male; Organometallic Compounds; Salicylates; Young Adult

2008

Other Studies

1 other study(ies) available for tetrakis-mu-acetylsalicylato-dicopper(ii) and salicylates

ArticleYear
Non-steroidal anti-inflammatory drug-copper complex modulation of polymorphonuclear leukocyte migration.
    Biochemical pharmacology, 1990, Feb-01, Volume: 39, Issue:3

    Topics: Acetates; Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Movement; Chemotaxis, Leukocyte; Indomethacin; Molecular Structure; Neutrophils; Organometallic Compounds; Pleurisy; Rats; Salicylates

1990